Treatment for thyroid eye disease should be personalized, with joint input from endocrinologists and ophthalmologists, according to two speakers.
The ATA and European Thyroid Association (ETA) presented a brief overview of a proposed joint consensus statement on the management of thyroid eye disease. The statement, which was drafted by a task force of seven thyroidologists and two ophthalmologists from both associations, addresses how providers should approach thyroid eye disease, patient assessment and management based on disease severity.
“Most decisions about treatment are best made